Award
National Institute of Allergy and Infectious Diseases 1R43AI195168-01
A sensitive and specific serology test for evaluating potency of whole cell Pertussis vaccines
Recipient
IMMPORT THERAPEUTICS, INC.
Award Amount
$300,000.00
Ceiling
$300,000.00
Awarded
August 25, 2025
Identifier
1R43AI195168-01
NIH/NIAID awarded approximately $300,000 to IMMPORT THERAPEUTICS, INC. for developing a sensitive and specific serology test to evaluate the potency of whole cell Pertussis vaccines, replacing the outdated Kendrick assay.
Description
The project involves developing a serology test to evaluate the potency of whole cell pertussis vaccines. The project aims to replace the outdated Kendrick assay with a more reliable serological test and involves collaboration with the Developing Countries Vaccine Manufacturing Network.